Risankizumab in Severe Asthma — A Phase 2a, Placebo-Controlled Trial

2021 ◽  
Vol 385 (18) ◽  
pp. 1669-1679
Author(s):  
Christopher E. Brightling ◽  
Parameswaran Nair ◽  
David J. Cousins ◽  
Renaud Louis ◽  
Dave Singh
Sign in / Sign up

Export Citation Format

Share Document